Antipsychiatric Medication Errors in Children Boarded in a Pediatric Emergency Department

Usha Sethuraman1, Nirupama Kannikeswaran1, Ahmad Farooqi2

  • 1From the Division of Emergency Medicine, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan.

Pediatric Emergency Care
|August 18, 2021
PubMed

Insights

Pediatric emergency departments see many mental health visits. This study found high rates of medication errors, especially omission errors, in children with mental health conditions boarded for over six hours.

Area of Science:

  • Pediatric Emergency Medicine
  • Child and Adolescent Psychiatry
  • Medication Safety

Background:

  • Pediatric emergency department (PED) visits for mental health concerns have significantly increased.
  • Children with mental health conditions are often boarded in PEDs for extended periods, raising concerns about care quality.

Purpose of the Study:

  • To describe medication errors in children with mental health conditions who were boarded in a PED for more than six hours.
  • To identify the types and frequency of medication errors associated with antipsychiatric prescriptions in this vulnerable population.

Main Methods:

  • Retrospective study of children aged 6-18 with psychiatric complaints and a length of stay >6 hours in the PED (2014-2015).
  • Excluded admitted patients and those not on home medications.
  • Collected data on demographics, antipsychiatric medication types and doses, and medication errors.

Main Results:

  • A total of 974 medication errors occurred in 491 (72.7%) of 676 included children.
  • Omission errors were the most common (76.6%), followed by commission errors (9.0%).
  • Antidepressant and antipsychotic classes were most frequently involved; 3 or more antipsychiatric medications were associated with prescription errors.

Conclusions:

  • High incidence of medication errors, particularly omission errors, in antipsychiatric prescriptions for children boarded in PEDs.
  • Urgent need for improved medication reconciliation processes.
  • Integration of psychiatric medication databases between PEDs and pharmacies is crucial to reduce errors.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
46
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
55
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
56
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
121
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
274